Home Markets Pfizer in deal with China’s 3SBio to license cancer drug candidate, take equity stake Pfizer in deal with China’s 3SBio to license cancer drug candidate, take equity stake Andrew M May 20, 2025 comments off Tweet on Twitter Share on Facebook Google+ Pinterest Original source: https://www.investing.com/news/stock-market-news/pfizer-signs-up-to-6-billion-licensing-deal-with-chinas-3sbio-for-cancer-drug-4053872 cancer China Market Updates Pfizer